The 6.7% dividend yield on offer from (NYSE: PFE) is both a sign of opportunity and risk. A lot will happen over the next five years that will determine if that dividend is sustainable. But even if it isn't, there is a material turnaround opportunity for investors if they take a risk and buy Pfizer today.

Pfizer is one of the largest pharmaceutical companies in the world. The drug industry is complex, and competition is fierce. Pfizer has been a long-term survivor, but that doesn't mean it hasn't gone through difficult periods. And the lofty yield is a sign that it is in the middle of a difficult period right now. It will almost certainly survive, but it isn't clear that the dividend will -- at least, not in its entirety.

 

Continue reading

Source Fool.com